Prevalence of non-Alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

PLoS ONE

Volumn 12, Issue 3, 2017, Pages

  Le, Michael H ^a   Devaki, Pardha ^b   Ha, Nghiem B ^c,d   Jun, Dae Won ^e   Te, Helen S ^f   Cheung, Ramsey C ^d,g   Nguyen, Mindie H ^d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e Hanyang University Medical Center   (South Korea)

^f UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^g VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NONALCOHOLIC FATTY LIVER; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; PREVALENCE; RISK FACTOR; SCORING SYSTEM; UNITED STATES; AGED; LIVER; LIVER CIRRHOSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION; PATHOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; FEMALE; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; NUTRITION SURVEYS; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; UNITED STATES;

EID: 85016303631     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0173499     Document Type: Article

References (41)

1. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-Aged population utilizing ultrasound and liver biopsy: A prospective study. Gastroenterology 2011; 140(1):124-131. https://doi.org/10.1053/j.gastro.2010.09.038
2. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-Alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 2012; 55(6):2005-2023. https://doi.org/10.1002/hep.25762
3. Abd El-Kader SM, El-Den Ashmawy EMS. Non-Alcoholic fatty liver disease: The diagnosis and management. World Journal of Hepatology 2015; 7(6):846-858. https://doi.org/10.4254/wjh.v7.i6.846
4. Kim CH, Younossi ZM. Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome. Cleve Clin J Med 2008; 75:721-728
5. Paschos P, Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009; 13 (1):9-19
6. Chitturi S, Farrell GC, Hashimoto E, Saibara T, Lau GK, Sollano JD. Non-Alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines. Asia-Pacific Working Party on NAFLD. J Gastroenterol Hepatol 2007; 22:778-787 https://doi.org/10.1111/j.1440-1746.2007.05001.x
7. Bellentani S, Scaglioni F, Marino M, Bedogni G. Epidemiology of non-Alcoholic fatty liver disease. Dig Dis 2010; 28:155-161. https://doi.org/10.1159/000282080
8. Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther 2015; 41:65-76 https://doi.org/10.1111/apt.13012
9. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006; 43 (2 Suppl 1):S99-S112.
10. Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, et al. The Fatty Liver Index: A simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterology 2006; 6:33. https://doi.org/10.1186/1471-230X-6-33
11. Meffert PJ, Baumeister SE, Lerch MM, Mayerle J, Kratzer W, VoÈlzke H. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis. The American Journal of Gastroenterology 2014; 109(9):1404-1414. https://doi.org/10.1038/ajg.2014.155
12. Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study. Clinical Gastroenterology and Hepatology 2013; 11(9):1201-1204. https://doi.org/10.1016/j.cgh.2012.12.031
13. Yang BL, Wu WC, Fang KC, Wang YC, Huo TI, Huang YH, et al. External validation of fatty liver index for identifying ultrasonographic fatty liver in a large-scale cross-sectional study in Taiwan. PloS One 2015; 10(3):e0120443. https://doi.org/10.1371/journal.pone.0120443
14. Lee YH, Bang H, Park YM, Bae JC, Lee BW, Kang ES, et al. Non-laboratory-based self-Assessment screening score for non-Alcoholic Fatty liver disease: development, validation and comparison with other scores. PloS One 2014, 9(9), e107584. https://doi.org/10.1371/journal.pone.0107584
15. Cuthbertson DJ, Weickert MO, Lythgoe D, Sprung VS, Dobson R, Shoajee-Moradie F, et al. External validation of the fatty liver index and lipid accumulation product indices, using 1H-magnetic resonance spectroscopy, to identify hepatic steatosis in healthy controls and obese, insulin-resistant individuals. European Journal of Endocrinology 2014, 171(5), 561-569. https://doi.org/10.1530/EJE-14-0112
16. Huang X, Xu M, Chen Y, Peng K, Huang Y, Wang P, et al. Validation of the Fatty Liver Index for Nonalcoholic Fatty Liver Disease in Middle-Aged and Elderly Chinese. Medicine 2015, 94(40), e1682. https://doi.org/10.1097/MD.0000000000001682
17. Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology 2007; 45:846-854. https://doi.org/10.1002/hep.21496
18. Musso G, Gambino R, Cassader M, Pagano G. Meta-Analysis: natural history of non-Alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 2011; 43(8):617-49. https://doi.org/10.3109/07853890.2010.518623
19. Machado MV, Cortez-Pinto H. Non-invasive diagnosis of non-Alcoholic fatty liver disease: A critical appraisal. J Hepatology 2013; 58:1007-1019
20. Castera L, Vilgrain V, Angulo P. Noninvasive evaluation of NAFLD. Nature Reviews Gastroenterology and Hepatology 2013; 10(11):666-675. https://doi.org/10.1038/nrgastro.2013.175
21. Ratziu V, Bellentani S, Cortez-Pinto H, Day C, Marchesini G. A position statement on NAFLD/NASH based on the EASL 2009 special conference. J Hepatol 2010; 53(2):372-384. https://doi.org/10.1016/j. jhep.2010.04.008
22. NCHS. National Health and Nutrition Examination Survey (NHANES). Available at: http://www.cdc.gov/nchs/nhanes.htm (accessed September 26, 2015).
23. Zipf G, Chiappa M, Porter KS, et al. National Health and Nutrition Examination Survey: Plan and operations, 1999-2010. National Center for Health Statistics. Vital Health Stat 1(56). 2013.
24. Data Linkage Team. Comparative analysis of the NHIS public-use and restricted-use linked mortality files: 2015 public-use data release National Center for Health Statistics. February 2015. Hyattsville, Maryland.
25. National Center for Health Statistics. Office of Analysis and Epidemiology, NCHS 2011 Linked Mortality Files Matching Methodology, September, 2013. Hyattsville, Maryland. Available at the following address: http://www.cdc.gov/nchs/data-Access/data-linkage/mortality/linkage-methods-Analytical-support/2011-linked-mor tality-file-matching-methodology.pdf
26. Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. Journal of Hepatology 2011; 54(4):753-759. https://doi.org/10.1016/j.jhep. 2010.07.040
27. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 2002; 106:3143-3421.
28. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27 (6):1487-1495.
29. StataCorp, L.P. (1985). Stata survival analysis and epidemiological tables reference manual. Stata-Corp LP, College Station, Texas.
30. Johnson CL, Paulose-Ram R, Ogden CL, et al. National Health and Nutrition Examination Survey: Analytic guidelines, 1999-2010. National Center for Health Statistics. Vital Health Stat 2(161). 2013.
31. NCHS. National Health and Nutrition Examination Survey: Analytic guidelines, 2011-2012. National Center for Health Statistics. Available at: http://www.cdc.gov/nchs/data/nhanes/analytic-guidelines-11-12.pdf (accessed September 26, 2015).
32. NCHS. Key Concepts About Weighting in NHANES. Available at: http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/Weighting/OverviewKey.htm (accessed September 26, 2015).
33. Kim D, Kim WR, Kim HJ, Therneau TM. Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States. Hepatology 2013; 57(4):1357-1365. https://doi.org/10.1002/hep.26156
34. Neuschwander-Tetri BA, Clark JM, Bass NM, Van Natta ML, Unalp-Arida A, Tonascia J, et al. Clinical, laboratory and histological associations in adults with nonalcoholic fatty liver disease. Hepatology 2010, 52(3), 913-924. https://doi.org/10.1002/hep.23784
35. Browning JD, Szczepaniak LS, Dobbins R, Numermberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40 (6):1387-1395. https://doi.org/10.1002/hep.20466
36. Lazo M, Hernaez R, Eberhardt MS, Bonekamp S, Kamel I, Guallar E, et al. Prevalence of nonalcoholic fatty liver disease in the United States: The third national health and nutrition examination survey, 1988-1994. American Journal of Epidemiology 2013, 178(1), 38-45. https://doi.org/10.1093/aje/kws448
37. Wiley TE, Brown J, & Chan J. Hepatitis C infection in African Americans: its natural history and histological progression. The American journal of Gastroenterology 2002. 97(3): p. 700-6., 97(3), 6-8. https://doi.org/10.1111/j.1572-0241.2002.05555.x
38. Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver related mortality in non-Alcoholic fatty liver disease. J Hepatol 2008; 49:608-612. https://doi.org/10.1016/j.jhep.2008.06.018
39. Ditah IC, Saeian K, Ngwa TN, Njei B, Bhat Z, Kamath P, et al. The Association Between Nonalcoholic Fatty Liver Disease and Noninvasively Assessed Fibrosis and Mortality: A 23 Years Prospective Population-Based Study [Abstract]. Gastroenterology 2016; 150(4): Suppl 1, S-1054-1055
40. Unalp-Arida A, & Ruhl CE. Noninvasive fatty liver markers predict liver disease mortality in the U.S. population. Hepatology 2016, 63(4), 1170-1183. https://doi.org/10.1002/hep.28390
41. Adams LA, Lymp JF, St Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: A population-based cohort study. Gastroenterology 2005; 29:113-121.